Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

COLY-MYCIN S

COLISTIN SULFATE

Standard Dose
EQ 25MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview COLY-MYCIN S is listed in Drugs@FDA under application 050355 (NDA).

Marketing status: Discontinued Active ingredient COLISTIN SULFATE Form and strength SUSPENSION;ORAL - EQ 25MG BASE/5ML Sponsor PARKE DAVIS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview COLY-MYCIN S is listed in Drugs@FDA under application 050355 (NDA). Marketing status: Discontinued Active ingredient COLISTIN SULFATE Form and strength SUSPENSION;ORAL - EQ 25MG BASE/5ML Sponsor PARKE DAVIS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
COLY-MYCIN S (COLISTIN SULFATE) | Drug Monograph | MedicHelpline